Covid-19, Lung Cancer
Conditions
Keywords
covid-19, coronavirus, lung cancer
Brief summary
This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members. The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.
Interventions
None listed
Sponsors
Spanish Lung Cancer Group
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with lung cancer * Patients who have contracted COVID-19 infection
Exclusion criteria
* Patients diagnosed with lung cancer but no confirmation of COVID-19 infection.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical data of lung cancer patients with COVID-19 diagnoses | From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years | Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as clinical data. |
| Diagnosis data | From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years | Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as data about diagnosis |
| Treatments received | From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years | Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as treatments received |
| Prognostic factors | From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years | Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as prognostic factors. |
Countries
Spain
Outcome results
None listed